Iw. Wainer et Cp. Granvil, STEREOSELECTIVE SEPARATIONS OF CHIRAL ANTICANCER DRUGS AND THEIR APPLICATION TO PHARMACODYNAMIC AND PHARMACOKINETIC STUDIES, Therapeutic drug monitoring, 15(6), 1993, pp. 570-575
In the past few years, it has become clear that individual stereo-isom
ers-especially the enantiomers-of a biologically active chiral molecul
e may differ in potency, pharmacological action, metabolism, toxicity,
plasma disposition, and urine excretion kinetics. This situation exis
ts in all classes of therapeutically active agents including chiral an
ticancer agents. The chiral compounds used in standard and experimenta
l cancer chemotherapy include leucovorin (LV), ifosfamide (IFF), buthi
onine sulfoximine (BSO), and verapamil (VER). Analytical methods for s
tereoselective separation of each of these compounds have been develop
ed and applied to pharmacokinetic and pharmacodynamic studies. Pharmac
ological differences have been found between stereoisomers of all of t
hese compounds and it is evident that the clinical effectiveness of th
ese agents would be enhanced by the administration of only a single is
omer.